Kestrel Therapeutics
0 followers
Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patien... Read more
Org chart
Frank Haluska
President And CEO
Frank Haluska
Collapse
Mark Bilodeau
Chief Scientific Officer
Ross Pettit
Svp, Head Of Development Operations
Omar A.
Vice President
Shyam Karki
Vice President And Head Of CMC
